Kemira reached a settlement with CDC in the damage claim litigation in Dortmund related to hydrogen peroxide business in 1994-2000

Kemira Oyj
Press Release
October 16, 2017 at 3.00 pm (CET+1)

Kemira reached a settlement with CDC in the damage claim litigation in Dortmund related to hydrogen peroxide business in 1994-2000

Kemira reached a settlement with CDC Cartel Damage Claims Hydrogen Peroxide SA and CDC Holding SA (together "CDC") in the damage claim litigation in Dortmund, Germany. The settlement concerns claims assigned to CDC based on which CDC claimed compensation for alleged damages relating to the alleged old infringement of competition law in the hydrogen peroxide business during 1994-2000. Kemira has agreed to pay to CDC as compensation and costs EUR 12.7 million recognized in the third quarter of 2017.

Kemira will continue to defend in the pending legal action filed by CDC in Amsterdam, Netherlands related to alleged old infringement of competition law in the sodium chlorate business in 1994-2000 against Kemira Chemicals Oy (former Finnish Chemicals Oy). Kemira acquired Finnish Chemicals in 2005.

"We are satisfied with the settlement as it removes the uncertainty related to the litigation case for business conducted in 1994-2000", says Jari Rosendal, President and CEO.

For more information, please contact:

Kemira Oyj
Jukka Hakkila, Group General Counsel
Tel. +358 10 862 1690 

Olli Turunen, Vice President, Investor Relations
Tel.  +358 10 862 1255

Kemira is a global chemicals company serving customers in water intensive industries. We provide expertise, application know-how and chemicals that improve our customers' product quality, process and resource efficiency. Our focus is on pulp & paper, oil & gas and water treatment. In 2016, Kemira had annual revenue of around EUR 2.4 billion and 4,800 employees. Kemira shares are listed on the Nasdaq Helsinki Ltd.
www.kemira.com